CAMZAVA

Serial Number 90002817
606

Registration Progress

Application Filed
Jun 16, 2020
Under Examination
Feb 2, 2021
Approved for Publication
Dec 8, 2020
Published for Opposition
Dec 8, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: CAMZAVA
Previous Owner: Sagent Pharmaceuticals, Inc.
Classes: 005

Trademark Image

CAMZAVA

Basic Information

Serial Number
90002817
Filing Date
June 16, 2020
Published for Opposition
December 8, 2020
Abandonment Date
September 4, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 4, 2023
Classes
005

Rights Holder

Sagent Pharmaceuticals, Inc.

03
Address
1901 North Roselle Road, Suite 450
Schaumburg, IL 60195

Ownership History

Sagent Pharmaceuticals, Inc.

Original Applicant
03
Schaumburg, IL

Sagent Pharmaceuticals, Inc.

Owner at Publication
03
Schaumburg, IL

Legal Representation

Attorney
Mark A. Paskar

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

33 events
Date Code Type Description Documents
Sep 5, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 4, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 29, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 2, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 27, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 6, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Feb 6, 2023 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Feb 6, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
Feb 6, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 3, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 1, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 1, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 1, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 24, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 22, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 22, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 22, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 14, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 14, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 14, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 2, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 8, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 8, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 18, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 2, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 25, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 25, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 25, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 18, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 13, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 19, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of chronic pancreatitis; oral serine protease inhibitor for the treatment of chronic pancreatitis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005